Table 5. Association of UCP polymorphisms with cardiovascular risk factors.
UCP2 A55V | UCP2 -866 | UCP3 -55C/T | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Model | Pc | OR | 95%CI | Pc | OR | 95%CI | Pc | OR | 95%CI | |
BMI >30 kg/cm2 | Recessive | 0.003 | 1.64 | 1.30-2.06 | 0.063 | 1.87 | 1.18-2.45 | 0.540 | 2.50 | 0.42-12.76 |
Additive | 0.001 | 1.44 | 1.15-1.80 | 0.030 | 1.45 | 1.16-1.81 | 0.197 | 1.60 | 0.88-2.09 | |
HT >140 mmHg | Recessive | 0.069 | 1.84 | 0.99-3.42 | 0.221 | 2.03 | 1.05-3.93 | 0.007 | 6.53 | 5.16-8.27 |
Additive | 0.052 | 1.33 | 1.00-1.77 | 0.049 | 1.72 | 1.23-2.41 | 0.011 | 6.55 | 5.21-8.31 | |
Hypercholesterolemia > 160 mg/dL | Recessive | 0.051 | 0.23 | 0.15-0.36 | 0.006 | 3.41 | 2.22-5.26 | 0.007 | 2.53 | 1.92-3.44 |
Additive | 0.062 | 0.22 | 0.18-0.28 | 0.038 | 1.65 | 1.26-2.17 | 0.011 | 2.56 | 1.95-3.49 | |
LDL-C >130 mg/dL | Recessive | 0.070 | 0.23 | 0.14-0.37 | 0.096 | 1.96 | 1.22-3.16 | 0.618 | 2.00 | 0.42-9.51 |
Additive | 0.015 | 3.01 | 2.40-3.78 | 0.030 | 0.14 | 0.10-0.19 | 0.236 | 3.03 | 1.94-4.63 | |
Hypertriglyceridemia >150 mg/dL | Recessive | 0.066 | 0.57 | 0.39-0.84 | 0.151 | 2.63 | 1.76-3.92 | 0.006 | 1.99 | 1.61-2.53 |
Additive | 0.059 | 0.53 | 0.44-0.65 | 0.100 | 2.20 | 1.81-2.67 | 0.010 | 2.01 | 1.69-2.62 | |
Hypoalphalipoproteinemia < 40 mg/dL | Recessive | 0.168 | 1.56 | 1.07-2.26 | 0.910 | 1.04 | 0.71-1.52 | 0.862 | 1.37 | 0.38-4.86 |
Additive | 0.054 | 1.33 | 1.11-1.60 | 0.296 | 0.90 | 0.75-1.08 | 0.984 | 1.01 | 0.72-1.42 | |
T2DM | Recessive | 0.086 | 2.08 | 1.22-3.52 | 0.001 | 2.72 | 1.64-4.50 | 0.007 | 2.26 | 1.70-3.01 |
Additive | 0.050 | 2.09 | 1.63-2.69 | < 0.001 | 2.85 | 1.74-4.65 | 0.011 | 2.30 | 1.74-3.06 |
All associations were tested using logistic regression adjusting for age, gender, smoking habits and physical activity. BMI: body mass index, HT: hypertension; LDL-C: Low density lipoprotein-cholesterol; T2DM: Type 2 diabetes mellitus. Bonferroni correction was made multiplying by 7 comparisons (Pc). Significant p values are in bold.